SECOND AMENDMENT TO AGREEMENT AND PLAN OF MERGERAgreement and Plan of Merger • March 8th, 2019 • Arsanis, Inc. • Biological products, (no disgnostic substances) • Delaware
THIS SECOND AMENDMENT TO AGREEMENT AND PLAN OF MERGER, dated as of March 8, 2019 (this “Amendment”), is entered into by and among Arsanis, Inc., a Delaware corporation (“Public Company”), Artemis AC Corp., a Delaware corporation and a wholly-owned subsidiary of Public Company (“Merger Sub”), and X4 Pharmaceuticals, Inc., a Delaware corporation (the “Merger Partner” and together with Public Company and Merger Sub, the “Parties”).
